Analysts at Wedbush reiterated an Outperform rating on shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. With a rating of Outperform on the …

Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) had its price target increased by equities researchers at Citigroup Inc. from $21.00 to $25.00.Citigroup Inc. currently has a rating of Buy on the stock. A number of other analysts have spoken on the company …